India launches nanomedicine framework with 210 R&D projects and global congress
The story in brief
India has established a regulatory framework for nanopharmaceuticals through guidelines by DBT, ICMR, and CDSCO. The World Congress on Nanomedicine 2026 is being held under ISNS and ISNM. The government supports 210 R&D projects with ₹174 crore, focusing on innovations like oral insulin nanoparticles and nanobots for breast cancer.